Baiyunshan (00874): Subsidiary Guangyao Phase II Fund Signs Partnership Agreement I with Guangyao Capital and Guangkai Fund to Establish Guangyao Guangkai Fund

Stock News

2025/12/29

Baiyunshan (00874) announced details regarding its subsidiary enterprise, Guangyao Phase II Fund's participation in the establishment of the Guangyao Guangkai Fund and the Guangyao Liwan Fund. On December 29, 2025, Guangyao Phase II Fund entered into Partnership Agreement I with Guangyao Capital and Guangkai Fund concerning the formation of the Guangyao Guangkai Fund. Partnership Agreement I became officially effective on the same date, with no changes to its principal terms. As of the date of this announcement, Partnership Agreement II related to the establishment of the Guangyao Liwan Fund has not yet been formally executed. The company will issue a separate announcement following the signing of Partnership Agreement II, in accordance with the Hong Kong Listing Rules.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1102120592"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1102120592\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1102120592?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-29 19:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102120592","market":"fut","top_or_hot":-1,"title":"Baiyunshan (00874): Subsidiary Guangyao Phase II Fund Signs Partnership Agreement I with Guangyao Capital and Guangkai Fund to Establish Guangyao Guangkai Fund","media":"Stock News","content":"<p>Baiyunshan (00874) announced details regarding its subsidiary enterprise, Guangyao Phase II Fund's participation in the establishment of the Guangyao Guangkai Fund and the Guangyao Liwan Fund. On December 29, 2025, Guangyao Phase II Fund entered into Partnership Agreement I with Guangyao Capital and Guangkai Fund concerning the formation of the Guangyao Guangkai Fund. Partnership Agreement I became officially effective on the same date, with no changes to its principal terms. As of the date of this announcement, Partnership Agreement II related to the establishment of the Guangyao Liwan Fund has not yet been formally executed. The company will issue a separate announcement following the signing of Partnership Agreement II, in accordance with the Hong Kong Listing Rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baiyunshan (00874): Subsidiary Guangyao Phase II Fund Signs Partnership Agreement I with Guangyao Capital and Guangkai Fund to Establish Guangyao Guangkai Fund</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaiyunshan (00874): Subsidiary Guangyao Phase II Fund Signs Partnership Agreement I with Guangyao Capital and Guangkai Fund to Establish Guangyao Guangkai Fund\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-29 19:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Baiyunshan (00874) announced details regarding its subsidiary enterprise, Guangyao Phase II Fund's participation in the establishment of the Guangyao Guangkai Fund and the Guangyao Liwan Fund. On December 29, 2025, Guangyao Phase II Fund entered into Partnership Agreement I with Guangyao Capital and Guangkai Fund concerning the formation of the Guangyao Guangkai Fund. Partnership Agreement I became officially effective on the same date, with no changes to its principal terms. As of the date of this announcement, Partnership Agreement II related to the establishment of the Guangyao Liwan Fund has not yet been formally executed. The company will issue a separate announcement following the signing of Partnership Agreement II, in accordance with the Hong Kong Listing Rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0097","symbol_name":"医药电商","start_time":0,"source_url":"","article_id":"1102120592","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102120592","pubTimestamp":1767006621,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Baiyunshan (00874) announced details regarding its subsidiary enterprise, Guangyao Phase II Fund's participation in the establishment of the Guangyao Guangkai Fund and the Guangyao Liwan Fund. On...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600332":"白云山","BK0097":"医药电商","BK0028":"国家队","BK0239":"医药制造","BK0096":"民营医院","BK0183":"MSCI概念","BK1606":"中医药概念","BK1515":"抗疫概念","BK1191":"制药","BK1521":"挪威政府全球养老基金持仓","BK0012":"证金概念","00874":"白云山","BK0188":"融资融券","BK0070":"员工持股","BK1197":"保健护理产品经销商","BK0196":"行业龙头","BK0175":"白马股"},"translate_title":"白云山(00874)：子公司光耀二期基金与光耀资本、广开基金签署合伙协议I设立光耀广开基金","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":1,"00874":1},"content_text":"Baiyunshan (00874) announced details regarding its subsidiary enterprise, Guangyao Phase II Fund's participation in the establishment of the Guangyao Guangkai Fund and the Guangyao Liwan Fund. On December 29, 2025, Guangyao Phase II Fund entered into Partnership Agreement I with Guangyao Capital and Guangkai Fund concerning the formation of the Guangyao Guangkai Fund. Partnership Agreement I became officially effective on the same date, with no changes to its principal terms. As of the date of this announcement, Partnership Agreement II related to the establishment of the Guangyao Liwan Fund has not yet been formally executed. The company will issue a separate announcement following the signing of Partnership Agreement II, in accordance with the Hong Kong Listing Rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}